摘要
除降糖作用外,钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)的心肾保护功能也日益引起重视。本文就SGLT2i对心衰的作用研究的进展作一综述,旨在为心衰的治疗提供新思路。
In addition to hypoglycemic effect,cardio-renal protective function of sodium-glucose cotransporter 2 inhibitors(SGLT2i)has also attracted increasing attention.The present article makes a review on research progress of role of SGLT2i on heart failure,aiming at providing new thinking for treatment of heart failure.
作者
荆睿
乔虹
JING Rui;QIAO Hong(Department of Endocrinology,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)
出处
《心血管康复医学杂志》
CAS
2023年第3期279-282,共4页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
心力衰竭
钠-葡萄糖转运体2
降血糖药
Heart failure
Sodium-glucose transporter 2
Hypoglycemic agents
